Your browser doesn't support javascript.
loading
Prognostic relevance of miRNA-155 methylation in anaplastic glioma.
Schliesser, Maximilian Georg; Claus, Rainer; Hielscher, Thomas; Grimm, Christiane; Weichenhan, Dieter; Blaes, Jonas; Wiestler, Benedikt; Hau, Peter; Schramm, Johannes; Sahm, Felix; Weiß, Elisa K; Weiler, Markus; Baer, Constance; Schmidt-Graf, Friederike; Schackert, Gabriele; Westphal, Manfred; Hertenstein, Anne; Roth, Patrick; Galldiks, Norbert; Hartmann, Christian; Pietsch, Torsten; Felsberg, Joerg; Reifenberger, Guido; Sabel, Michael Christoph; Winkler, Frank; von Deimling, Andreas; Meisner, Christoph; Vajkoczy, Peter; Platten, Michael; Weller, Michael; Plass, Christoph; Wick, Wolfgang.
Afiliación
  • Schliesser MG; Department of Neurology, Heidelberg University Hospital and German Cancer Consortium, Clinical Cooperation Units, Germany.
  • Claus R; Clinical Cooperation Unit of Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Hielscher T; Division of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Grimm C; Department of Diagnostic and Interventional Neuroradiology, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany.
  • Weichenhan D; Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Blaes J; Department of Neurology, Heidelberg University Hospital and German Cancer Consortium, Clinical Cooperation Units, Germany.
  • Wiestler B; Clinical Cooperation Unit of Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Hau P; Division of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Schramm J; Clinical Cooperation Unit of Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Sahm F; Department of Neurology, Heidelberg University Hospital and German Cancer Consortium, Clinical Cooperation Units, Germany.
  • Weiß EK; Clinical Cooperation Unit of Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Weiler M; Neurology Clinic, Regensburg University, Regensburg, Germany.
  • Baer C; Neurosurgery Clinic, University of Bonn Medical Center, TU Munich, Munich, Germany.
  • Schmidt-Graf F; Department of Neuropathology, Heidelberg University Hospital and German Cancer Consortium, Clinical Cooperation Units, Germany.
  • Schackert G; Clinical Cooperation Unit of Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Westphal M; Department of Neurology, Heidelberg University Hospital and German Cancer Consortium, Clinical Cooperation Units, Germany.
  • Hertenstein A; Clinical Cooperation Unit of Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Roth P; Department of Neurology, Heidelberg University Hospital and German Cancer Consortium, Clinical Cooperation Units, Germany.
  • Galldiks N; Clinical Cooperation Unit of Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Hartmann C; Department of General Neurology, University Hospital Tübingen, Germany.
  • Pietsch T; Division of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Felsberg J; Department of General Neurology, University Hospital Tübingen, Germany.
  • Reifenberger G; Neurology Clinic, TU Munich, Munich, Germany.
  • Sabel MC; Neurosurgery Clinic, Dresden University Medical Center, Germany.
  • Winkler F; Neurosurgery Clinic, University Clinic Hamburg, Eppendorf, Germany.
  • von Deimling A; Department of Neurology, Heidelberg University Hospital and German Cancer Consortium, Clinical Cooperation Units, Germany.
  • Meisner C; Clinical Cooperation Unit of Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Vajkoczy P; Department of General Neurology, University Hospital Tübingen, Germany.
  • Platten M; Department of Neurology, University Hospital Zurich, Zurich, Switzerland.
  • Weller M; Neurology Clinic, Cologne University, Cologne, Germany.
  • Plass C; Department of Neuropathology, Heidelberg University Hospital and German Cancer Consortium, Clinical Cooperation Units, Germany.
  • Wick W; Clinical Cooperation Unit of Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Oncotarget ; 7(50): 82028-82045, 2016 Dec 13.
Article en En | MEDLINE | ID: mdl-27880937
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Biomarcadores de Tumor / Metilación de ADN / MicroARNs / Epigénesis Genética / Glioma Tipo de estudio: Prognostic_studies Idioma: En Revista: Oncotarget Año: 2016 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Biomarcadores de Tumor / Metilación de ADN / MicroARNs / Epigénesis Genética / Glioma Tipo de estudio: Prognostic_studies Idioma: En Revista: Oncotarget Año: 2016 Tipo del documento: Article